Bioxcel therapeutics announces nih nida grant to columbia university to support further studies of bxcl501 (sublingual dexmedetomidine) for treating opioid withdrawal

Multi-year-funded award to support a 160-patient, randomized-controlled study in patients undergoing opioid withdrawal treatment

BTAI Ratings Summary

BTAI Quant Ranking